curing cancer. in the clouds. the final frontier

33
WELCOME TO CABOT’S 25 TH ANNUAL INVESTMENT & WEALTH MANAGEMENT CONFERENCE Your interests and goals always come first.

Upload: cabot-wealth-management

Post on 08-Jul-2015

47 views

Category:

Economy & Finance


1 download

DESCRIPTION

Portfolio managers Dennis Wassung, CFA, and Craig Goryl, CFA, discuss Cabot Wealth Management's investment themes, including biotechnology and genomics, cloud computing and frontier markets. Presented on September 26, 2014.

TRANSCRIPT

Page 1: Curing Cancer. In the Clouds. The Final Frontier

WELCOME TO CABOT’S

25TH ANNUAL INVESTMENT & WEALTH MANAGEMENT CONFERENCE

Your interests and goals always come first.

Page 2: Curing Cancer. In the Clouds. The Final Frontier

Curing Cancer, In The Clouds

& The Final Frontier

PRESENTED BY:

DENNIS WASSUNG, CFA ®, PORTFOLIO MANAGER

CRAIG GORYL, CFA ®, PORTFOLIO MANAGER

Page 3: Curing Cancer. In the Clouds. The Final Frontier

Dennis Wassung, CFA®

Portfolio Manager

Cabot Wealth Management, Inc.216 Essex Street

Salem, Massachusetts 01970800-888-6468 eCabot.com

Curing CancerGenomics & Biotechnology

Page 4: Curing Cancer. In the Clouds. The Final Frontier

GenomicsWhat is it?

Genomics – The study of organisms’ hereditary information. An

organism’s genome is its complete set of DNA.

DNA – The chemical compound containing instructions for developing

and directing all the body’s activities. An identical copy is in each cell.

DNA Sequencing – The process of determining the exact order of the

chemical bases that make up DNA, about 6.2 billion in total for a human.

The map of a person’s DNA can tell us a lot about them, from their

eye color to their likelihood of developing cancer. Scientists

understand parts of the map, but most of it is still a mystery.

Page 5: Curing Cancer. In the Clouds. The Final Frontier

GenomicsWhy is this important?

Predictive Medicine – Based on my DNA, what are my chances of

developing a particular disease?

Testing & Diagnostics – What disease is this? Is it an aggressive form in

need of treatment, or is it better to wait?

Therapeutics – What causes this disease, and what drugs will cure it?

At the heart of genomics is the promise of personalized medicine. Because

of differences in DNA, treatments do not work the same for everyone.

Someday our current practice - prescribing the same drug for everyone who

has a given disease - will seem archaic. This is truly a revolution in

healthcare.

Page 6: Curing Cancer. In the Clouds. The Final Frontier

Why We Need Better, Targeted Drugs

Page 7: Curing Cancer. In the Clouds. The Final Frontier

Lower Cost Per Genome Drives Adoption

Page 8: Curing Cancer. In the Clouds. The Final Frontier

Next-Generation Sequencing (NGS)

Source: Illumina, Inc.

Page 9: Curing Cancer. In the Clouds. The Final Frontier

Oncology Market Evolving

Source: Illumina, Inc. & U.S. Department of Energy Office of Science

Page 10: Curing Cancer. In the Clouds. The Final Frontier

Evolving Biotechnology & BiopharmaLandscape

Source: Quintiles Transnational, Inc.

Page 11: Curing Cancer. In the Clouds. The Final Frontier

Market Evolution Toward The Patient

Source: Quintiles Transnational, Inc.

Page 12: Curing Cancer. In the Clouds. The Final Frontier

Where Are We Headed?

Source: Illumina, Inc.

Page 13: Curing Cancer. In the Clouds. The Final Frontier

Investment Opportunities

Gene Sequencing – Equipment & Technology solutions to rapidly and cost-effectively sequence DNA

Biotechnology – New Drug Development & Commercialization, Genetically-targeted drugs

Testing & Diagnostics – Testing for & diagnosing specific genetically defined diseases and condition.

Bioinformatics & Data Analytics – Analyzing the massive amounts of data created and gleaning critical information from gene sequencing

Page 14: Curing Cancer. In the Clouds. The Final Frontier

In The Clouds…

Cloud Computing – A Major Transition

Page 15: Curing Cancer. In the Clouds. The Final Frontier

Cloud Computing Benefits

Page 16: Curing Cancer. In the Clouds. The Final Frontier

$410 Billion Worldwide Software Market

Page 17: Curing Cancer. In the Clouds. The Final Frontier

Enterprise Software Market Evolution

Source: Veeva Systems, Inc.

Page 18: Curing Cancer. In the Clouds. The Final Frontier

Moving To The Cloud Saves Money

Source: IDC Research Cloud Software Analysis, Sep 2012; Veeva Systems

Page 19: Curing Cancer. In the Clouds. The Final Frontier

Industry-Specific Cloud Platforms

Sources: Demandware,

Euromonitor, Gartner,

eMarketer Global eCommerce

Page 20: Curing Cancer. In the Clouds. The Final Frontier

Investment Opportunities

Cloud Software (aka “Software-as-a-Service” or SaaS) –Enterprise Software “lease” business model gaining wide adoption – CRM, Marketing, HCM, ERP – Lots of attention from the Big Guys (Acquisitions)

Cloud Infrastructure – Internet and data center infrastructure needed to enable the “Cloud” in all of its forms

Industry Cloud Software Applications – Companies are developing and gaining traction with industry-specific cloud platforms – life sciences, financial services, eCommerce, etc.

Cybersecurity technology – Software and hardware solutions to protect consumers and companies, whose personal or business data reside in the cloud

Page 21: Curing Cancer. In the Clouds. The Final Frontier

Frontier Markets-Next to EmergeCRAIG GORYL, CFA

PORTFOLIO MANAGER

CABOT WEALTH MANAGEMENT

Page 22: Curing Cancer. In the Clouds. The Final Frontier

What are Frontier Markets?Frontier Markets are less developed than Emerging Markets. We view the investment universe in classes.

In order of market maturity (with examples):

1. United States*

2. Developed Markets (Germany, Canada, Japan)

3. Emerging Markets (Brazil, China, Russia, Mexico)

4. Frontier Markets (Kuwait, Nigeria, Argentina, Pakistan)

In terms of development, Frontier Markets are like Emerging Markets 20 years ago. But they are catching up at a faster rate.

*US is a Developed Market- a special case as our home country and the most advanced

Page 23: Curing Cancer. In the Clouds. The Final Frontier

What are Frontier Markets?

Source: Wall Street Journal

Page 24: Curing Cancer. In the Clouds. The Final Frontier

What are Frontier Markets?Frontier markets hold 35% of the world’s population, produce 16% of its economic output, and represent 4% of global market value

Source: Everest Capital

Page 25: Curing Cancer. In the Clouds. The Final Frontier

Why Frontier Markets?

1) ATTRACTIVE DEMOGRAPHICS

Growing working age population, the prime time for fertility and economic productivity

0

10

20

30

Kuwait Nigeria US Japan

% of Pop. Over 65 today

-10

0

10

20

Kuwait Nigeria US Japan

% Growth of Working Age Pop, 2015-2020

Low “elderly dependency ratio,” the resource transfer from young to old

Page 26: Curing Cancer. In the Clouds. The Final Frontier

Why Frontier Markets?

2) “LEAPFROGGING”

Skipping generations of technologies saves time, money and resources. Examples: photography, M-Pesa

Access to modern political and economic theory through an increasingly global education system

Source: Franklin Templeton

68%

50%

29%

24%

13%

11%

% of Mobile Phone Users Regularly Making or

Receiving Payments on their Phone

Page 27: Curing Cancer. In the Clouds. The Final Frontier

Why Frontier Markets?

3) RESOURCE RICH

Frontier markets contain about 40% of the world’s natural resource reserves and nearly 26% of gas reserves

They have an opportunity to avoid the “resource curse,” where corruption and inequality follow abundant natural resources (Russia, Mexico, South Africa)

Source: Everest Capital

Page 28: Curing Cancer. In the Clouds. The Final Frontier

Why Frontier Markets?

4) GROWING FAST 5)REASONABLY PRICED 6) GOOD QUALITY

Growth: Valuation: Quality:

Est. Sales

Growth

Rate '13-15

Est. EPS

Growth

Rate '13-16

Price/

Earnings

Est. Price/

Earnings

Price/

Book

Dividend

Yield

Return

on

Equity

Operating

Profit

Margin

Debt/

Equity

Debt/

Assets

United States 5% 12% 18.1 16.8 2.7 1.9% 15.0 14.0 104.8 23.9

Developed Int'l 2% 15% 17.6 15.1 1.6 3.3% 10.6 9.6 180.6 24.5

Emerging Mkts 4% 8% 13.4 12.2 1.5 2.7% 10.9 10.9 109.3 22.4

Frontier 28% 25% 12.0 11.2 1.8 3.7% 15.4 18.7 88.3 16.7

Green represents the most attractive metric. Red is least attractive.

Data: Bloomberg 9/19/14

Page 29: Curing Cancer. In the Clouds. The Final Frontier

Risky? Less Than You ThinkLOW DEPENDENCE ON FOREIGN CAPITAL

Frontier economies are self-sustaining. Infrastructure investment is fed by citizen savings, not hot foreign money.

LOW CORRELATION TO OTHER MARKETS

These markets and economies respond to military coups, typhoons, oil discoveries etc., not broad global macro events. Each country has idiosyncratic drivers.

Single country volatility is high, but low correlations mean lower collective volatility- see the chart.

Source: Wall Street Journal

Page 30: Curing Cancer. In the Clouds. The Final Frontier

Other Risks?

BALANCE

The main benchmark (MSCI Frontier Markets Index) is not well balanced.

Kuwait and Nigeria comprise almost half the index. Banks and other financial companies dominate.

Solution: Frontier markets should be part of a diversified portfolio

LIQUIDITY

Market access, company size, and share availability are barriers.

Most Frontier companies trade less than $3mil in value per day, raising the cost of entry and exit.

Solution: US-traded funds like FM & TFMAX are liquid but don’t solve the underlying issue

Page 31: Curing Cancer. In the Clouds. The Final Frontier

Return Comparison (2-year)

Page 32: Curing Cancer. In the Clouds. The Final Frontier

Thank you

Page 33: Curing Cancer. In the Clouds. The Final Frontier

2 1 6 E S S E X S T R E E T

S A L E M , M A 0 1 9 7 0

( 9 7 8 ) 7 4 5 - 9 2 3 3

( 8 0 0 ) 8 8 8 - M G M T

www.eCabot . com

info@eCabot . com